Siga Technologies SIGA
NASDAQ SIGA
$3.09 -0.11 (-3.44%)
As of: Sep 9, 2026 · 3:59 PM EDT

Siga Technologies (SIGA) Free Cash Flow (2010 - 2025)

Siga Technologies' (SIGA) quarterly Free Cash Flow came in at -$10.1 million in Q3 2025, down 36.43% on a YoY basis from -$15.9 million in Q3 2024, and down 116.02% quarter-over-quarter from $63.1 million in Q2 2025.

Analysis

Siga Technologies (SIGA) Free Cash Flow (2010 - 2025) Analysis & Trends

Siga Technologies (SIGA) has reported Free Cash Flow for 16 consecutive years, with -$10.1 million the latest figure, recorded in Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow fell 36.43% year-over-year to -$10.1 million; the trailing twelve-month figure through Sep 2025 stood at $116.3 million (up 62.77% YoY), and the FY2024 full-year result was $48.7 million, down 48.6% from the prior year.
  • Free Cash Flow slipped to -$10.1 million in Q3 2025 per SIGA's latest filing, from $63.1 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $79.0 million in Q4 2023 and bottomed at -$10.1 million in Q3 2025.
  • Historically, Free Cash Flow has averaged $13.5 million across 5 years, with a median of -$1.4 million in 2021.
  • The widest YoY moves for Free Cash Flow: up 1276.47% in 2022, down 393.58% in 2022.
  • Over 5 years, Free Cash Flow stood at $16.1 million in 2021, then plunged by 150.42% to -$8.1 million in 2022, then surged by 1074.95% to $79.0 million in 2023, then declined by 28.77% to $56.3 million in 2024, then sank by 117.95% to -$10.1 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$10.1 million, $63.1 million, and $7.0 million for Q3 2025, Q2 2025, and Q1 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 7.30 Bn
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 3.11 Bn
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn 4.48 Bn
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 6.20 Bn
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 302.00 Mn
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 43.79 Bn 43.79 Bn - -389.61 Mn
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 495.25 Mn
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 205.60 Mn
10 Siga Technologies 220.19 Mn 65.22 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -10.10 Mn
Jun 30, 2025 63.08 Mn
Mar 31, 2025 7.04 Mn
Dec 31, 2024 56.29 Mn
Sep 30, 2024 -7.41 Mn
Jun 30, 2024 5.95 Mn
Mar 31, 2024 -6.12 Mn
Dec 31, 2023 79.03 Mn
Sep 30, 2023 -5.10 Mn
Jun 30, 2023 -3.60 Mn
Mar 31, 2023 24.45 Mn
Dec 31, 2022 -8.11 Mn
Sep 30, 2022 -4.78 Mn
Jun 30, 2022 -2.21 Mn
Mar 31, 2022 56.71 Mn
Dec 31, 2021 16.08 Mn
Sep 30, 2021 1.63 Mn
Jun 30, 2021 -1.44 Mn
Mar 31, 2021 -4.82 Mn
Dec 31, 2020 45.95 Mn